Recent Interviews

Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".

Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".

John Jeffrey, CEO, Saturn Oil + Gas Inc.

John Jeffrey
CEO | Saturn Oil + Gas Inc.
Suite 1000 - 207 9 Ave SW, T2P 1K3 Calgary (CAN)


Saturn Oil + Gas CEO John Jeffrey: "Acquisition has increased production by 2,000%"

09. September 2021 | 11:42 CET

Nordex, Water Ways Technologies, MorphoSys: How investors invest in the future

  • Investments
Photo credits:

The future is traded on the stock exchange. But what does it look like? It is not easy to make concrete predictions. That is one of the reasons why there are both positive and negative surprises on the stock market. But as an investor, you can help the odds, for example, by focusing on megatrends. Demographics, health, and sustainability are trends that will still be in place in ten years. We present three possible investments.

time to read: 3 minutes by Nico Popp
ISIN: NORDEX SE O.N. | DE000A0D6554 , Water Ways Technologies | CA9411881043 , MORPHOSYS AG O.N. | DE0006632003



Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author

Nordex: Where is the journey heading?

Nordex has been a sustainable stock from the very beginning - ten years ago, Nordex was already one of the top sellers on the trading floor. Recently, the share came under a bit of pressure. The reason: profitability was not as high as the market had hoped. On the other hand, however, the order books are full. As a result, Nordex is a good example of short-term irritations that should not unsettle investors: The climate change is near, renewable energies will dominate or at least be enormously expanded in the future. For Nordex, this can only be good news.

But what is the share price doing? It has been drifting sideways for weeks with a slight downward trend. If it slips below the EUR 15 mark, things could get uncomfortable for the stock once again. In any case, a downward slide could last until EUR 13. Conversely, new upward potential could arise above EUR 17. Fundamentally, things do not look bad for the wind turbine manufacturer, but the share price is not keeping up. That suggests that it is better to watch the stock from the sidelines.

Water Ways Technologies makes agriculture smart

One stock where an overly passive stance can quickly pay off is Water Ways Technologies. The Israel-based Company with a home exchange in Canada develops irrigation solutions for agribusinesses. Smart agriculture has a vital role, especially in times of scarce water and increasing demand for food that is ideally healthy and free of pesticides. Water scarcity is considered one of the greatest risks facing humanity. Political analysts have even predicted wars due to water shortages or polluted rivers. Rivers are not considered lifelines for nothing - if too much water is taken from upstream or the water is polluted, conflicts of great consequence can arise. Water Ways Technologies addresses the root cause - agriculture. According to studies, agriculture is responsible for 70% of the world's water withdrawals. Acting smarter here seems like an intelligent approach.

Israel has always been innovative when it comes to growing crisp vegetables and sweet fruits on barren land. Consequently, Israel is also considered the motherland of agricultural technology. Water Ways Technologies continues this tradition, using sensors and apps to make the most efficient use of water. The current Company's forerunners were founded in Israel in 2003, and Water Ways Technologies has been successfully listed in Toronto since 2019. The Company has since known how to leverage investor capital successfully: In June 2019, they established a subsidiary in Canada and in February 2020, a subsidiary company in China. One year later, the most successful deal in the Company's history followed in Asia with an order worth CAD 4 million. 2021 was also successful for Water Ways, with the first half of the year bringing revenues of CAD 12.1 million and EBITDA of CAD 832,000. Today, the Company is in a better position than a year ago in almost all areas. In addition, Water Ways Technologies plans to actively communicate its success in Europe in the coming weeks and months. Water is a precious commodity - likely, there is also good money to be made from it on the stock market. With Water Ways, investors can bet on a dynamic company that has just entered the growth path.

MorphoSys: No party mood despite approval

Business is traditionally volatile for companies such as biotech group MorphoSys. The Company recently received European market approval for a drug to treat malignant diseases of the lymphatic system. But new drugs always have high start-up costs. At the end of the first half, MorphoSys posted a loss of EUR 101 million. The share is also very weak again after a few positive days. The shock of the half-year loss has not yet been digested on the stock market, making the share rather uninteresting.

Even if cancer drugs are a great hope for many patients, the MorphoSys share is currently not. Nordex is also presently lacking in imagination. Water Ways Technologies, on the other hand, looks much better. It is a small company that has only just found its way onto the growth path and operates in an attractive sector.


Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author

Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.

Related comments:

16. September 2021 | 11:58 CET | by André Will-Laudien

Siemens Healthineers, PuriflOH, Fresenius, Novavax - Focusing on health!

  • Investments

The pandemic outbreak in 2020 ushered in a new era. People's health is once again moving to the center of attention. Politicians worldwide see themselves obligated to make public life safe, but whether this will be 100% successful remains questionable. Ultimately, it will depend on the commitment of private companies to what extent the existing health issues can be solved and by what means. On the capital markets, the healthcare sector has been sailing on the highest wave for months because the dangers for billions of people need to be reduced, and framework conditions for public life need to be created. Who benefits the most?


14. September 2021 | 12:02 CET | by Fabian Lorenz

MorphoSys, HelloFresh, Aspermont - Price halving or rebound?

  • Investments

Investors are likely to speculate on a rebound in the Valneva share in the coming days; because the price slide of over 30% on Monday was violent. Stifel analysts see sales and earnings estimates for 2020 and 2021 in jeopardy after the UK government unexpectedly canceled a major order for the COVID-19 vaccine under development. Investors have been waiting for a rebound in MorphoSys shares for some time. The latest analyst assessment gives little hope. If Bernstein Research has its way, HelloFresh could soon be down almost 50%. Aspermont seems ripe for a rebound - the share is interesting from a chart perspective, and analysts advise buying.


10. September 2021 | 11:16 CET | by Stefan Feulner

GameStop, wallstreet:online, Nikola - It goes on blithely

  • Investments

The ECB is following the lead of the FED. Although some council members warned not to ignore the risk of too high inflation, an end to the ultra-loose monetary policy is not in sight. Only the purchase of government and corporate securities under the Corona emergency purchase program should be "moderately" lower in the fourth quarter. The pro-growth decision is a balm for the stock markets. New highs should follow after the last mini-corrections.